title: Bladder cancer: Restaging TUR reduces recurrence and progression risk.
abstract: Transurethral resection (TUR) is widely used to manage early-stage bladder cancer. A recent study has confirmed that a second, or restaging, TUR is associated with a lower risk of progression and cancer-related death. Restaging TUR is therefore recommended as a standard of care in patients with stage T1 bladder cancer.
authors.affiliation: Sidney Kimmel Center for Prostate and Urologic Cancers, 353 East 68th Street, New York, NY 10021, USA. dalbagng@mskcc.org
authors.forename: Guido
authors.initials: G
authors.lastname: Dalbagni
mesh_terms: D015653:Cystectomy / Q000379:methods; D018450:Disease Progression; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D012307:Risk Factors; D014521:Urethra; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery*